The Keith Michael Andrus Cardiac Award funds research into the causes and treatment of cardiomyopathy in Friedreich’s ataxia, supported by the Friedreich's Ataxia Research Alliance.
Funder: Friedreich's Ataxia Research Alliance
Due Dates: February 15, 2027 (Letter of Intent) | April 15, 2027 (Full Application)
Funding Amounts: Up to $125,000 per year for 1 or 2 years; direct costs only; typically one award per year.
Summary: Supports research advancing understanding or treatment of cardiomyopathy in Friedreich’s ataxia.
The Keith Michael Andrus Cardiac Award from the Friedreich's Ataxia Research Alliance (FARA) funds innovative research projects dedicated to understanding and addressing cardiac complications—particularly cardiomyopathy—associated with Friedreich’s ataxia (FA). This competitive, annual award honors Keith Michael Andrus and aims to catalyze scientific advances or therapeutic strategies that improve cardiac health and outcomes for individuals affected by FA. Both basic and translational research proposals are welcome, provided they focus on cardiac involvement in FA.